| Literature DB >> 23865540 |
Ping Ouyang1, Krzysztof Rakus, Maxime Boutier, Anca Reschner, Baptiste Leroy, Maygane Ronsmans, Guillaume Fournier, Sophie Scohy, Bérénice Costes, Ruddy Wattiez, Alain Vanderplasschen.
Abstract
Cyprinid herpesvirus 3 (CyHV-3), a member of the family Alloherpesviridae, is the causative agent of a lethal disease in common and koi carp. CyHV-3 ORF134 encodes an interleukin-10 (IL-10) homologue. The present study was devoted to this ORF. Transcriptomic analyses revealed that ORF134 is expressed as a spliced gene belonging to the early-late class. Proteomic analyses of CyHV-3 infected cell supernatant demonstrated that the ORF134 expression product is one of the most abundant proteins of the CyHV-3 secretome. To investigate the role of ORF134 in viral replication in vitro and in virulence in vivo, a deleted strain and a derived revertant strain were produced using BAC cloning technologies. The recombinant ORF134 deleted strain replicated in vitro comparably to the parental and the revertant strains. Infection of fish by immersion in water containing the virus induced comparable CyHV-3 disease for the three virus genotypes tested (wild type, deleted and revertant). Quantification of viral DNA by real time TaqMan PCR (in the gills and the kidney) and analysis of carp cytokine expression (in the spleen) by RT-qPCR at different times post-infection did not revealed any significant difference between the groups of fish infected with the three virus genotypes. Similarly, histological examination of the gills and the kidney of infected fish revealed no significant differences between fish infected with ORF134 deleted virus versus fish infected with the control parental or revertant strains. All together, the results of the present study demonstrate that the IL-10 homologue encoded by CyHV-3 is essential neither for viral replication in vitro nor for virulence in common carp.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23865540 PMCID: PMC3750702 DOI: 10.1186/1297-9716-44-53
Source DB: PubMed Journal: Vet Res ISSN: 0928-4249 Impact factor: 3.683
Primers and probes.
| PCR | RT-PCR | | | ||
| CyHV-3 ORF3 | ORF3InF | | • | TATGCCCACATGATGCTGTT | DQ657948 |
| | ORF3InR | | • | CAGTCAGACCCTTCCTCTGC | |
| CyHV-3 ORF55 | ORF55InF | • | | AGCGCTACACCGAAGAGTCC | |
| | ORF55stopR | • | | TCACAGGATAGATATGTTACAAG | |
| | ORF55ATGF | | • | ATGGCTATGCTGGAACTGG | |
| | ORF55InR | | • | GGCGCACCCAGTAGATTATG | |
| CyHV-3 ORF78 | ORF78InF | | • | TGGACGACGAACACCCTTC | |
| | ORF78InR | | • | GGTAGAGGGTACAACCACG | |
| CyHV-3 ORF132 | ORF132InF | | • | GGATCCGTTTTCTGGGTCTG | |
| | ORF132InR | | • | CTCAATCCCTCACCGACCTC | |
| CyHV-3 ORF133 | ORF133InF | | • | GACGAGATCCCTATCCGCAG | |
| | ORF133InR | | • | GACCTCGGGTATGGTCGGTA | |
| CyHV-3 ORF134 | ORF134stopF | | • | TCAATGTTTGCGCTTGGTTTTC | |
| | ORF134ATGR | | • | ATGTTCCTTGCAGTGCTAC | |
| | ORF134InF | • | | GGTTTCTCTTTGTAGTTTTCCG | |
| | ORF134InR | • | | CACCCCAACTTTTGAGACAAC | |
| | ORF134outseqF | • | | GTCAACATGGACGAGCGTGA | |
| | ORF134outseqR | • | | GTGGGGATATCAAACACGCA | |
| CyHV-3 ORF135 | ORF135InF | | • | ACACCACCAACGAGACATGC | |
| | ORF135InR | | • | CTTTTCGGACCAGAAGACCG | |
| Carp β-actin | Actin-F | | • | ATGTACGTTGCCATCCAGGC | M24113 |
| | Actin-R | | • | GCACCTGAACCTCTCATTGC | |
| H1- | 134 | | | ATGTTCCTTGCAGTGCTACTAACCG | Warming et al. [ |
| CGACCATCTTCTTCGAGGCTCGGGG | |||||
| CCTGTTGACAATTAATCATCGGCA | |||||
| | 134 | | | TCAATGTTTGCGCTTGGTTTTCATG | |
| TTCTTGACGTCTTTTGCGACCAGGA | |||||
| TCAGCACTGTCCTGCTCCTT | |||||
| H1-ORF134-H2 | H1F | | | GCTCATCAATCGCAGCAGCA | DQ657948 |
| cassette | |||||
| | H2R | | | CAAGCCATTATCCTGTTGGG | |
| CyHV-3 ORF89 | KHV-86F | | | GACGCCGGAGACCTTGTG | AF411803 |
| | KHV-163R | | | CGGGTTCTTATTTTTGTCCTTGTT | |
| | KHV-109P | | | (6FAM)CTTCCTCTGCTCGGCGAGCACG(BHQ1) | |
| Carp glucokinase | CgGluc-162F | | | ACTGCGAGTGGAGACACATGAT | AF053332 |
| | CgGluc-230R | | | TCAGGTGTGGAGCGGACAT | |
| | CgGluc-185P | | | (6FAM)AAGCCAGTGTCAAAATGCTGCCCACT(BHQ1) | |
| 40S | 40S-F | | | CCGTGGGTGACATCGTTACA | AB012087 |
| | 40S-R | | | TCAGGACATTGAACCTCACTGTCT | |
| IL-1β | IL-1β-F | | | AAGGAGGCCAGTGGCTCTGT | AJ245635 |
| | IL-1β-R | | | CCTGAAGAAGAGGAGGCTGTCA | |
| TNF-α1 and 2 | TNF-α1 and 2-F | | | GCTGTCTGCTTCACGCTCAA | AJ311800 |
| | TNF-α1 and 2-R | | | CCTTGGAAGTGACATTTGCTTTT | |
| CXCa | CXCa-F | | | CTGGGATTCCTGACCATTGGT | AJ421443 |
| | CXCa-R | | | GTTGGCTCTCTGTTTCAATGCA | |
| IL-10 | IL-10-F | | | CGCCAGCATAAAGAACTCGT | AB110780 |
| | IL-10-R | | | TGCCAAATACTGCTCGATGT | |
| IFNγ-2 | IFNγ-2-F | | | TCTTGAGGAACCTGAGCAGAA | AM168523 |
| | IFNγ-2-R | | | TGTGCAAGTCTTTCCTTTGTAG | |
| IL-6 | IL-6M17-F | | | CACATTGCTGTGAGGGTGAA | AY102633 |
| IL-6M17-R | GCATCCATAGGCTTTCTGCT | ||||
Underlined: 50bp corresponding to CyHV-3 sequence.
Figure 1Schematic representation of the strategy used to produce CyHV-3 FL BAC ORF134 recombinants. (A) The region of CyHV-3 genome encoding ORF134 is illustrated for wild type (WT), ORF134 Del galK and ORF134 Del genotypes. (B) Flow chart of stages performed to produce FL BAC ORF134 recombinant plasmids and to reconstitute virus strains.
Figure 2Determination of ORF134 kinetic class of transcription. CCB cells were infected with CyHV-3 FL strain, in absence (Untreated) or presence of CHX or PAA as described in Materials and methods. At the indicated time post-infection, expression of IE ORF3, E ORF55, L ORF78, ORF134 and carp β-actin was studied by a RT-PCR approach. On the left RT-PCR or PCR represent PCR products generated when the RT was performed or omitted from the reactions, respectively. On the right, control PCR reactions were performed using genomic DNA as template (Ctrl+) or no template (Ctrl-).
CyHV-3 and host proteins identified by 2D-LC MS/MS in the supernatant of CyHV-3 infected CCB cells.
| | | | | | | |
| gi|129560530 | ORF12, TNF receptor superfamily homologue | 19.2 | 671 | 14 | 1.49 | |
| gi|129560652 | ORF134, Interleukin 10 homologue | 14.8 | 304 | 6 | 1.02 | |
| gi|84181525 | ORF116, predicted membrane glycoprotein | 30.4 | 185 | 4 | 0.26 | |
| gi|84181523 | ORF119, putative uncharacterized protein containing an hydrophobic region | 15.5 | 94 | 2 | 0.25 | |
| gi|129560569 | ORF52, predicted membrane glycoprotein | 39.2 | 44 | 1 | 0.10 | |
| | | | | | | |
| gi|122891218 | Novel protein (zgc:103659) ( | 51.7 | 410 | 13 | 0.42 | |
| gi|136429 | Trypsin ( | 25.1 | 281 | 9 | 0.53 | |
| gi|297262447 | Predicted keratin, type II cytoskeletal 1-like isoform 6 ( | 65.3 | 268 | 3 | 0.12 | |
| gi|37590349 | Enolase 1, alpha ( | 47.4 | 255 | 8 | 0.35 | |
| gi|326670662 | Predicted collagen alpha-3(VI) chain-like ( | 11.3 | 227 | 8 | 0.17 | |
| gi|51949771 | Fibronectin 1b ( | 279.3 | 213 | 8 | 0.08 | |
| gi|52218922 | Pigment epithelium-derived factor precursor ( | 45.0 | 158 | 3 | 0.17 | |
| gi|416696 | Beta-2-microglobulin ( | 13.5 | 152 | 8 | 1.79 | |
| gi|1351907 | Serum albumin ( | 71.2 | 149 | 11 | 0.36 | |
| gi|395744345 | Predicted keratin, type II cytoskeletal 1 ( | 25.8 | 139 | 3 | 0.15 | |
| gi|229552 | Albumin ( | 68.1 | 136 | 10 | 0.38 | |
| gi|63102189 | Pgd protein (D. rerio) | 53.7 | 134 | 4 | 0.14 | |
| gi|15718387 | Gelatinase ( | 75.5 | 125 | 5 | 0.15 | |
| gi|1703244 | Fructose-bisphosphate aldolase C ( | 39.8 | 124 | 4 | 0.20 | |
| gi|169154447 | Fibronectin 1 ( | 275.6 | 117 | 5 | 0.05 | |
| gi|15149946 | Procollagen type I alpha 1 chain ( | 49.4 | 117 | 5 | 0.34 | |
| gi|148726027 | Cadherin 11, osteoblast ( | 88.9 | 112 | 5 | 0.13 | |
| gi|4885063 | Fructose-bisphosphate aldolase C ( | 39.8 | 107 | 2 | 0.20 | |
| gi|28336 | Mutant beta-actin (beta'-actin) ( | 42.1 | 105 | 2 | 0.09 | |
| gi|28317 | Unnamed protein product ( | 59.7 | 104 | 3 | 0.13 | |
| gi|337758 | Pre-serum amyloid P component ( | 25.5 | 100 | 3 | 0.32 | |
| gi|223582 | Histone H4 ( | 11.2 | 99 | 5 | 0.84 | |
| gi|47971186 | Carp C1q-like molecule ( | 20.3 | 98 | 2 | 0.19 | |
| gi|223061 | Ubiquitin ( | 8.5 | 92 | 4 | 0.31 | |
| gi|27806751 | Alpha-2-HS-glycoprotein precursor ( | 39.2 | 90 | 4 | 0.32 | |
| gi|47086029 | Myristoylated alanine-rich C kinase substrate 2 ( | 21.0 | 86 | 2 | 0.18 | |
| gi|2133885 | N-cadherin precursor ( | 87.4 | 80 | 3 | 0.09 | |
| gi|18859555 | Wnt inhibitory factor 1 precursor ( | 43.2 | 79 | 3 | 0.09 | |
| gi|34595971 | Prion-like protein 1 ( | 55.6 | 75 | 2 | 0.14 | |
| gi|208609649 | Collagen type I alpha 3 ( | 137.7 | 75 | 1 | 0.03 | |
| gi|47085905 | 14-3-3 protein beta/alpha-B ( | 27.5 | 75 | 3 | 0.47 | |
| gi|6644111 | Nucleoside diphosphate kinase-Z1 ( | 17.4 | 72 | 2 | 0.22 | |
| gi|16974825 | Chain A, Solution Structure Of Calcium-Calmodulin N-Terminal Domain ( | 8.5 | 70 | 2 | 0.49 | |
| gi|41152406 | FK506 binding protein 1A, 12kDa ( | 11.8 | 69 | 3 | 1.39 | |
| gi|189527793 | Predicted neuroblast differentiation-associated protein AHNAK ( | 642.1 | 65 | 2 | 0.01 | |
| gi|37492 | Alpha-tubulin (H. sapiens) | 50.8 | 65 | 2 | 0.07 | |
| gi|33989505 | Tissue inhibitor of metalloproteinase 2b ( | 24.7 | 64 | 2 | 0.15 | |
| gi|8176557 | Heart fatty acid binding protein ( | 15.3 | 61 | 1 | 0.26 | |
| gi|37181 | Tissue inhibitor of metalloproteinases, Type-2 ( | 21.4 | 59 | 2 | 0.18 | |
| gi|437972 | Fibrillin-2 ( | 334.8 | 59 | 1 | 0.01 | |
| gi|37367051 | Osteopontin ( | 23.2 | 53 | 1 | 0.16 | |
| gi|45544646 | Cold inducible RNA binding protein isoform 2 ( | 19.2 | 52 | 2 | 0.20 | |
| gi|51328294 | Fstl1b protein ( | 39.6 | 50 | 1 | 0.09 | |
| gi|82245450 | Triosephosphate isomerase B ( | 27.1 | 50 | 1 | 0.14 | |
| gi|34014734 | Clusterin ( | 52.5 | 50 | 1 | 0.07 | |
| gi|47228578 | Unnamed protein product ( | 77.5 | 49 | 1 | 0.05 |
Figure 3Identification of CyHV-3 ORF134 by 2D-LC MS/MS in the supernatant of CyHV-3 infected CCB cells. (A) Data collected on ORF134 through 2D-LC MS/MS analysis of cell culture supernatant. (B) Sequential alignment of CyHV-3 ORF134 and Cyprinus carpio IL-10. Sequence coverage: detected peptides are presented in rectangles.
Figure 4Structural analysis of the FL BAC ORF134 recombinant plasmids and derived CyHV-3 recombinant strains. The CyHV-3 FL BAC, FL BAC ORF134 Del and FL BAC ORF134 Rev plasmids and the genome of the FL BAC revertant, FL BAC revertant ORF134 Del and FL BAC revertant ORF134 Rev strains were analyzed by SacI restriction (left panel) and further tested by southern blotting using probes corresponding to ORF55 (central panel) and ORF134 (right panel). White-outlined black arrowheads and white arrows indicate restriction fragments containing ORF55 and ORF134 loci, respectively. Marker sizes (MS) are indicated on the left.
Figure 5PCR analysis of the FL BAC ORF134 recombinant plasmids and derived CyHV-3 recombinant strains. The CyHV-3 FL BAC, FL BAC ORF134 Del and FL BAC ORF134 Rev plasmids and the genome of the FL BAC revertant, FL BAC revertant ORF134 Del and FL BAC revertant ORF134 Rev strains were analyzed by PCR using the forward primer ORF134outseqF and the reverse primer ORF134outseqR (Table 1). MS are indicated on the left.
Figure 6Transcriptional analysis of CyHV-3 ORF134 genome region. CCB cells were infected with the indicated recombinant strains at a MOI of 0.5 PFU/cell. Twenty-four hours post-infection, expression of CyHV-3 ORF55, ORF132, ORF133, ORF134, ORF135 and carp β-actin was studied by the RT-PCR approach described in the Materials and methods. On the left RT-PCR or PCR represent PCR products generated when the RT was performed or omitted from the reactions, respectively. On the right, control PCR reactions were performed using genomic DNA as template (Ctrl+) or no template (Ctrl-).
Figure 7Effect of ORF134 deletion on viral growth in vitro. Replication kinetics of CyHV-3 ORF134 recombinant strains were compared with those of the FL BAC revertant strain using a multi-step growth assay (see Materials and methods). The data presented are the means ± standard errors of triplicate measurements.
Figure 8Cumulative survival rates of common carp infected with CyHV-3 recombinant strains. On day 0, common carp (n = 30 fish per tank), with an average weight of 3.8 g ± 1.5 g (mean ± SD), were mock-inoculated (2 tanks, panel D) or inoculated (panels A-C) by immersion for 2 h in water containing 4 PFU/mL, 40 PFU/mL or 400 PFU/mL of the indicated CyHV-3 strains. On day 42 post-infection (arrow), surviving fish were challenged by addition of two fish infected with the parental FL strain. Percentages of surviving carp are expressed according to days post-infection.
Figure 9PCR detection and characterization of CyHV-3 genomes recovered from infected carp. The analyses reported in this figure are the follow-up of the experiment described in Figure 8. Three mock-infected carp (selected randomly before the challenge) and three dead carp from each of the groups infected with the FL BAC Revertant, FL BAC Revertant ORF134 Del and FL BAC Revertant ORF134 Rev strains were dissected. DNA was extracted from the kidney. PCRs were performed with the ORF55InF/ORF55stopR and ORF134InF/ORF134InR pairs of primers (Table 1). FL strain DNA and distilled water were used as positive (Ctrl+) and negative (Ctrl-) controls, respectively.
Figure 10Viral load in gill and kidney. Common carp (n = 36 fish per tank), with an average weight of 10.7 g ± 3.2 g (mean ± SD), were inoculated by immersion for 2 h in water containing 100 PFU/mL of the indicated CyHV-3 strains. At different times post-inoculation, six infected fish were randomly selected per tank, euthanized and dissected. Six mock-infected fish were used as negative controls. Gill, kidney and spleen were harvested and stored in RNAlater® at −80 °C. DNA was extracted from gill (panel A) and kidney (panel B) and analyzed by real-time TaqMan PCR for quantification of viral genome copies. The results are expressed as the means ± SD of the data observed for the 6 fish analyzed per time point. Spleen were treated for quantification of carp gene expression by RT-qPCR (see Figure 11).
Figure 11RT-qPCR analysis of cytokines. Kinetics of gene expression was measured in the spleen of mock-infected fish and fish infected with CyHV-3 ORF134 recombinants (see legend of Figure 10). Gene expression was normalized relative to the expression of the S11 protein of the 40S ribosomal subunit. Data are presented as mean ± SD (n = 6). Symbol (*) indicates statistical differences (p ≤ 0.05) observed between infected and mock-infected fish. Symbol (a) indicates statistical differences (p ≤ 0.05) observed for a specific time point between groups of fish infected with different CyHV-3 recombinants.
Figure 12Histopathological characterization of the lesions induced by CyHV-3 ORF134 recombinants in the gills. Common carp (n = 20 fish per tank), with an average weight of 6 g ± 1.6 g (mean ± SD), were inoculated by immersion for 2 h in water containing 40 PFU/mL of the FL BAC revertant, FL BAC revertant ORF134 Del or FL BAC revertant ORF134 Rev strains. At different times post-inoculation (2, 4, 6 and 8 days), three infected fish were randomly selected per tank, euthanized and dissected. Three mock-infected fish were used as negative controls. Gills (present figure) and kidney (see Figure 13) were collected and processed for histological examination. Slides corresponding to each sampling point were grouped according to the viral strain used for the inoculation and were submitted to histopathological examinations by two independent examiners using a double-blind test mode. The images in this figure are representative of the analysis of one selected fish per group. Bar, 30 μm.
Figure 13Histopathological characterization of the lesions induced by CyHV-3 ORF134 recombinants in the kidney. The fish infection methods are described in the legend of Figure 12.